3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
1
Lung Diseases
1
Interventions
Paclitaxel
3
Carboplatin
3
selpercatinib
2
durvalumab
2
Nivolumab
2
Blood Specimen Collection
2
zipalertinib
1
ceralasertib
1
atezolizumab
1
Pemetrexed
1
Omacor
1
Ipilimumab
1
Docetaxel
1
Diarylheptanoids
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lung Diseases
×
zipalertinib
×
Clear all
NCT05973773
2026-05-28
REZILIENT3
Taiho Oncology, Inc.
Phase 3
Active not recruiting
285 enrolled